Home › Psychotic Disorders › Ohio
Psychotic Disorders clinical trials in Ohio
7 studies for Psychotic Disorders are looking for participants at sites in Ohio.
Cities in Ohio
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, Dayton
- Clinical Site, Independence
RecruitingPhase 2
Ages 55 to 90 · All sexes · Updated Sep 30, 2026 · NCT06887192A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Local Institution - 1265, Cleveland
- Ohio State University, Columbus
- Local Institution - 1258, Dayton
- and 1 more
RecruitingPhase 3
Ages 55 to 90 · All sexes · Updated Sep 22, 2026 · NCT06585787A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Independence
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT07105111A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- Clinical Site, North Canton
- Clinical Site, West Chester
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Sep 1, 2026 · NCT07459647REACH Study (Recovery Environments: Assessing Cognitive & Brain Health in Community Mental Health)
- Case Western Reserve University, Cleveland
Recruiting
Ages 18 to 50 · All sexes · Updated Aug 17, 2026 · NCT07006935A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)
- Local Institution - 0029, Cleveland
- Insight Clinical Trials LLC - Independence, Independence
RecruitingPhase 3
Ages 55 to 90 · All sexes · Updated Jun 30, 2026 · NCT06947941Normobaric Oxygen Therapy for Individuals With First-Episode Psychosis
- Harding Hospital, Columbus
Recruiting
Ages 15 to 35 · All sexes · Updated Feb 25, 2026 · NCT04368039From ClinicalTrials.gov, data retrieved Oct 3, 2026. Each study sets its own eligibility; the study team decides who can join.